FDA Approves First Commercial Zika Virus Test

Until now, patients who wanted the test had to go through their state or local health departments

The Food and Drug Administration approved the first commercial U.S. test Thursday to diagnose the Zika virus, NBC News reported.

Quest Diagnostics will use the same method that government labs use to look for Zika virus in a patient's blood.

The Centers for Disease Control and Prevention recommends testing pregnant women with Zika symptoms, those who have traveled to areas where Zika is spreading while they are pregnant and women who have had sex with someone who has Zika.

Doctors can now order the test through Quest, which says it can get results in three to five days. Until now, patients who wanted the test had to go through their state or local health departments.  

A spokeswoman for Quest said most patients with a health plan may receive some coverage benefits. Uninsured patients can expect to pay $120 for the test, she said. 

Read More

Contact Us